Ascelia Pharma AB

Prospectus ID: 24-18775

Document type
Standalone prospectus
Home member state
Sweden
Prospectus type
Standalone Prospectus
Structure
Single document prospectus
Approval / filing date
16 Aug 2024
National document ID
24-18775
Issuer LEI
5493002YR9VCJJPWYN08
Language(s)
Swedish

ISINs

  • SE0010573113
  • SE0022725438

Passported to

Member states to which this prospectus has been notified under Art. 25 of Regulation (EU) 2017/1129.

  • Denmark

Last verified: 2 Nov 2026

Data sourced from the ESMA prospectus register, updated weekly.

Regulatory Q&As

Browse Prospectus Regulation Q&As → Official ESMA interpretations

See also

Passporting details — 1 host member state → ESMA Prospectus Passporting Register

📋 Track EU financial regulation continuously

Forseti monitors EU financial regulation and delivers personalised alerts anchored to verified official sources.

14-day free trial. No credit card required.